Wells Fargo’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$281K Sell
7,640
-84,830
-92% -$3.12M ﹤0.01% 4178
2025
Q1
$3.27M Buy
92,470
+4,143
+5% +$146K ﹤0.01% 2438
2024
Q4
$3.86M Buy
88,327
+30,155
+52% +$1.32M ﹤0.01% 2318
2024
Q3
$2.64M Buy
58,172
+2,899
+5% +$131K ﹤0.01% 2564
2024
Q2
$2.15M Buy
55,273
+11,471
+26% +$445K ﹤0.01% 2672
2024
Q1
$1.41M Buy
43,802
+3,836
+10% +$124K ﹤0.01% 2922
2023
Q4
$1.15M Sell
39,966
-22,678
-36% -$650K ﹤0.01% 3023
2023
Q3
$1.73M Sell
62,644
-36,021
-37% -$997K ﹤0.01% 2711
2023
Q2
$2.64M Buy
98,665
+27,249
+38% +$729K ﹤0.01% 2527
2023
Q1
$1.55M Buy
71,416
+69,610
+3,854% +$1.51M ﹤0.01% 2884
2022
Q4
$43K Sell
1,806
-1,816
-50% -$43.3K ﹤0.01% 4627
2022
Q3
$71K Buy
3,622
+383
+12% +$7.51K ﹤0.01% 4489
2022
Q2
$63K Sell
3,239
-22,030
-87% -$428K ﹤0.01% 4651
2022
Q1
$646K Sell
25,269
-20,951
-45% -$536K ﹤0.01% 3967
2021
Q4
$1.16M Sell
46,220
-12,614
-21% -$318K ﹤0.01% 3743
2021
Q3
$1.62M Buy
58,834
+41,915
+248% +$1.15M ﹤0.01% 3660
2021
Q2
$536K Buy
16,919
+4,679
+38% +$148K ﹤0.01% 4319
2021
Q1
$561K Sell
12,240
-70,054
-85% -$3.21M ﹤0.01% 4330
2020
Q4
$3.26M Buy
82,294
+35,617
+76% +$1.41M ﹤0.01% 3081
2020
Q3
$1.62M Buy
46,677
+6,801
+17% +$237K ﹤0.01% 3421
2020
Q2
$1.26M Buy
39,876
+31,443
+373% +$992K ﹤0.01% 3558
2020
Q1
$185K Buy
+8,433
New +$185K ﹤0.01% 4566